Our results demonstrated that Cathepsin B is one of the important mediators of TMAO-induced endothelial injury, Cathepsin B may be a therapeutic target for treatment or prevention of endothelial injury and associated cardiovascular diseases. This evidence concerns the gene CTSB and cardiovascular disorder.